Management tracks: GSK, Orphazyme, Kymera and more

By Mary Romeo, Assistant Editor | Jul 15, 2019 | 11:15 PM GMT

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) declined to confirm news reports stating it will appoint Jonathan Symonds as chairman to succeed Philip Hampton, who has served in the role since 2015.